Mira Dx is a genomics company dedicated to the development and commercialization of novel microRNA-based diagnostic tests.
Company (Alive / Active)
New Haven, 06501
Connecticut, United States
|Investor||Investor Type||Location||Participating Rounds|
|Title||Application Date||Patent Date||Status
(Patent / Application)
|Methods for treating or preventing cancer in a kras-variant patient and for diagnosing risk of developing multiple primary breast tumors||Dec 11, 2015||Application|